ArticleOncogene2023

Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.

Qiangnu Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.